BUY WITH BOTH HANDS DOWN $1 MORE DOLLAR
TJX The TJX Companies, Inc. @$96.80 <---- BUY POINT-!
$97.65-0.43(-0.44%)
HIT $96.66 YESTERDAY! INCREDIBLE CHART READ///////////
BUY WITH BOTH HANDS DOWN $1 MORE DOLLAR
TJX The TJX Companies, Inc. @$96.80 <---- BUY POINT-!
$97.65-0.43(-0.44%)
There was some news on it earlier this week, on cnbc or bloomberg... i didn't pay attention, but i do know they said something about it.PLCE
wow, almost half the float bought on 9th and 13th
Halted @ $35
Gotta be a short squeeze
DID ANYONE SEE 60 MINUTES?
THEY HAD THE GUY THAT INVENTED AI-- COOL DUDE. HE'S WORRIED.
HE MENTIONED GOOD AND BAD ASPECTS AND ON THE GOOD SIDE HE SAID AI IS VERY GOOD AT SELECTING DRUG CANDIDATES TO TREAT DISEASES.. PROBABLY BETTER THAN MAN-
SO I'M THINKING MS WOOD IS ONTO SOMETHING:
Recursion Pharmaceuticals: A biotech pioneer
Recursion Pharmaceuticals is a biotech company that develops novel treatments for rare diseases and cancer. Perhaps more importantly, though, it also has a cutting-edge drug discovery platform called Recursion OS, which uses artificial intelligence (AI) to identify promising therapeutic targets without human bias.
Recursion OS could revolutionize the pharmaceutical industry by accelerating the drug discovery process, reducing the time and cost of clinical trials, and enabling the development of breakthrough therapies. Cathie Wood holds roughly $52 million of the biotech's shares in her ARK Genomic Revolution ETF, and she has purchased the stock five times in the last 30 days at the time of this writing.
IDEA-> 1 MONTH DOWN 17.8% // 5 DAYS DOWN 9%
RXRX Recursion Pharmaceuticals, Inc.
$6.68-0.35(-4.98%)1:11 PM 10/09/23
AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley

Already have some from $21